![The F-35’s future: The power and cooling competition that could change everything [Video]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/09/240924_F35_moon_USAF-scaled-e1727200160419.jpg?#)
Revance Names New CEO to Drive Next Phase in Aesthetic Innovation
Revance Therapeutics has announced a leadership succession plan, with founder and CEO Jeff Bedard transitioning to the role of Executive Chairman and Nadeem Moiz, the current President and CFO, appointed as the incoming Chief Executive Officer. The post Revance Names New CEO to Drive Next Phase in Aesthetic Innovation appeared first on Global Cosmetics News.
THE WHAT? Revance Therapeutics has announced a leadership succession plan, with founder and CEO Jeff Bedard transitioning to the role of Executive Chairman and Nadeem Moiz, the current President and CFO, appointed as the incoming Chief Executive Officer.
THE DETAILS The leadership change is part of Revance’s strategic initiative to support its next phase of growth and innovation in the aesthetics sector. Nadeem Moiz, who has been instrumental in the company’s financial and operational strategies, will assume the CEO position, bringing a wealth of experience to drive the company’s objectives forward. Jeff Bedard will continue to play a significant role as Executive Chairman, focusing on long-term strategy and vision.
THE WHY? This transition aims to strengthen Revance’s leadership structure to better position the company for sustained growth in the competitive aesthetics market. By appointing a seasoned executive like Moiz as CEO, Revance seeks to enhance its operational efficiency and innovation capabilities, ensuring the company remains at the forefront of aesthetic advancements.
Source: PR Newswire
The post Revance Names New CEO to Drive Next Phase in Aesthetic Innovation appeared first on Global Cosmetics News.
